**Question:** All are true regarding oral hairy leukoplakia except: (Repeat)

A. Hairy leukoplakia is a viral infection caused by Epstein-Barr virus (EBV) in immunocompromised individuals.
B. The lesion is typically asymptomatic and does not cause any symptoms.
C. Oral hairy leukoplakia is a pre-cancerous condition that progresses to oral cancer.
D. Treatment with antiviral medications is not necessary in most cases.

**Correct Answer: C.**

**Core Concept:** Oral hairy leukoplakia is a viral infection primarily affecting the oral mucosa in immunocompromised patients, particularly those with HIV infection. The causative agent is the Epstein-Barr virus (EBV). The infection results in the development of white, hairy, and raised plaques on the oral mucosa.

**Why the Correct Answer is Right:**

Oral hairy leukoplakia is a viral infection and is associated with immunodeficiency, particularly HIV infection. As a result, the correct answer C ("Oral hairy leukoplakia is a pre-cancerous condition that progresses to oral cancer.") is incorrect because oral hairy leukoplakia is not inherently a pre-cancerous condition but rather a response to EBV infection in immunocompromised individuals. Although there is a higher risk of developing oral cancer in these patients, it is the underlying immunodeficiency, not the leukoplakia itself, that predisposes to malignancy.

**Why Each Wrong Option is Incorrect:**

A. Although EBV is the causative agent, the lesion is typically asymptomatic and does not cause any symptoms. Hence, stating that the lesion causes symptoms is incorrect.
B. The statement that oral hairy leukoplakia is always asymptomatic is not entirely true. While most cases are asymptomatic, some patients may experience symptoms such as burning sensation, pain, or discomfort in the affected area.
D. Treatment with antiviral medications is usually not necessary in most cases, as the lesion resolves spontaneously with the improvement of the immunodeficiency status in HIV patients. However, in cases with severe symptoms or when the lesion is associated with oral candidiasis, antiviral therapy may be considered.

**Clinical Pearl:**

In the context of HIV infection or other immunocompromised states, oral hairy leukoplakia is a marker for the underlying immunodeficiency and should prompt further evaluation for the immune status of the patient. Treatment is typically focused on addressing the immunodeficiency rather than the leukoplakia itself. Monitoring the patient's immune status and antiviral therapy may be essential in managing the disease process.

**Explanation of the Wrong Options:**

Option A is incorrect because not all cases of oral hairy leukoplakia are asymptomatic. A small percentage of patients may experience symptoms like burning sensation, pain, or discomfort in the affected area.

Option B is incorrect because antiviral therapy is not always necessary. Antiviral medications are usually not indicated for oral hairy leukoplakia unless the patient experiences severe